PEPTIDES

Generic Peptides

Our Generic Peptides

Atosiban Acetate
Cat #
Introduction Atosiban, sold under the brand name Tractocile among others, is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. It was developed by Ferring Pharmaceuticals in Sweden and first reported in the literature in 1985. Originally marketed by Ferring Pharmaceuticals, it is licensed in proprietary and generic forms for the delay of imminent preterm birth in pregnant adult women.
Sequence C43H67N11O12S2
MW 994.19
Reference 1. "Atosiban International Drug Names". Drugs.com. 10 April 2020. Retrieved 29 April 2020.
"Tractocile 7.5 mg/ml Solution for Injection - Summary of Product Characteristics (SmPC)". (emc). Retrieved 29 April 2020.

2. "Tractocile 7.5 mg/ml Concentrate for Solution for Infusion - Summary of Product Characteristics (SmPC)". (emc). 24 June 2013. Retrieved 29 April 2020.

4. "Tractocile EPAR". European Medicines Agency (EMA). Retrieved 29 April 2020. Public Domain This article incorporates text from this source, which is in the public domain.

5. Akerlund M, Carlsson AM, Melin P, Trojnar J (1985). "The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin". Acta Obstet Gynecol Scand. 64 (6): 499–504. doi:10.3109/00016348509156728. PMID 4061066. S2CID 25799128.
Fields of application
Synonyms
Structure
LIST